Current Atherosclerosis Reports

, 15:366

The Role of Bariatric Surgery in the Treatment of Type 2 Diabetes: Current Evidence and Clinical Guidelines

Lipid and Metabolic Effects of Gastrointestinal Surgery (F Rubino, Section Editor)

DOI: 10.1007/s11883-013-0366-0

Cite this article as:
Via, M.A. & Mechanick, J.I. Curr Atheroscler Rep (2013) 15: 366. doi:10.1007/s11883-013-0366-0
Part of the following topical collections:
  1. Topical Collection on Lipid and Metabolic Effects of Gastrointestinal Surgery


The incidence of type 2 diabetes (T2D) continues to rise worldwide. The management of T2D is challenging and therefore amenable to multimodality treatment options. Many published observations of obese individuals with T2D that have undergone bariatric surgery consistently demonstrate remarkable improvement and short-term remission of T2D. Recently published randomized trials confirm these findings and demonstrate significantly improved glycemic control following bariatric procedures, especially Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. However, the question of long-term remission remains uncertain. Clinicians may consider the use of bariatric surgery as a treatment option for certain obese patients with T2D who have failed intensive lifestyle intervention and conventional pharmacotherapy.


Bariatric surgeryRoux-en-Y gastric bypassLaparoscopic adjustable gastric bandLaparoscopic sleeve gastrectomyType 2 diabetes remission

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Division of Endocrinology and MetabolismBeth Israel Medical Center, Albert Einstein College of MedicineNew YorkUSA
  2. 2.Division of Endocrinology, Diabetes and Bone DiseaseIcahn School of Medicine at Mount SinaiNew York CityUSA